Kaplan–Meier survival analysis further corroborated these findings, demonstrating a significant association between negative SIRT3 expression and poorer overall prognosis, thereby underscoring SIRT3’s potential as a critical biomarker in pancreatic cancer prognosis. This evidence concerns the gene SIRT3 and familial pancreatic carcinoma.